PAVmed Inc Q3 2024 Earnings Call Transcript - Thomson StreetEvents

PAVmed Inc Q3 2024 Earnings Call Transcript

PAVmed Inc Q3 2024 Earnings Call Transcript - Thomson StreetEvents
PAVmed Inc Q3 2024 Earnings Call Transcript
Published Nov 14, 2024
9 pages (4944 words) — Published Nov 14, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of PAVM.OQ earnings conference call or presentation 14-Nov-24 1:30pm GMT

  
Brief Excerpt:

...Operator Good morning, and welcome to the PAVmed's third-quarter 2024 business update conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Matt Riley, PAVmed Director of Investor Relations. Please go ahead. Matt Riley ...

  
Report Type:

Transcript

Source:
Company:
PAVmed Inc
Ticker
PAVM.OQ
Time
1:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Ross Osborn - Cantor Fitzgerald - Analyst : Maybe starting off, could you share any learnings from your work with The Ohio State?


Question: Ross Osborn - Cantor Fitzgerald - Analyst : Okay. Great. And then I guess maybe regarding OpEx for PAVmed. How should we think about that in the coming quarters? I'm assuming maybe pretty steady ahead of any incremental financing?


Question: Anthony Vendetti - Anthony Vendetti - Analyst : Just a little more follow-up on the Veris program. So assuming you get the financing and so forth, is it still on track for submission with the FDA on a 510(k) basis before the first half of '25?


Question: Anthony Vendetti - Anthony Vendetti - Analyst : Okay. Great. And then in terms of the financing for the PMX incubator, you said you have lined up some financing already. How much total funding..... REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 14, 2024 / 1:30PM, PAVM.OQ - Q3 2024 PAVmed Inc Earnings Call


Question: Edward Woo - Ascendiant Capital - Analyst : Yes. Congratulations on all your progress. My question is on The Ohio State pilot. What does the competitive slate looks like? Were you guys competing against other diagnostic, remote diagnostic devices? Or did they have nothing before that?

Table Of Contents

PAVmed Inc Q2 2025 Earnings Call Transcript – 2025-08-14 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 14-Aug-25 12:30pm GMT

PAVmed Inc Annual Shareholders Meeting Transcript – 2025-06-18 – US$ 54.00 – Edited Transcript of PAVM.OQ shareholder or annual meeting 18-Jun-25 2:00pm GMT

PAVmed Inc Q1 2025 Earnings Call Transcript – 2025-05-15 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 15-May-25 12:30pm GMT

PAVmed Inc Q4 2024 Earnings Call Transcript – 2025-03-25 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 25-Mar-25 12:30pm GMT

PAVmed Inc Extraordinary Shareholders Meeting Transcript – 2025-01-15 – US$ 54.00 – Edited Transcript of PAVM.OQ shareholder or annual meeting 15-Jan-25 3:00pm GMT

PAVmed Inc Q2 2024 Earnings Call Transcript – 2024-08-13 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 13-Aug-24 12:30pm GMT

PAVmed Inc Annual Shareholders Meeting Transcript – 2024-06-20 – US$ 54.00 – Edited Transcript of PAVM.OQ shareholder or annual meeting 20-Jun-24 2:00pm GMT

PAVmed Inc Q4 2023 Earnings Call Transcript – 2024-03-27 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 27-Mar-24 12:30pm GMT

PAVmed Inc Q3 2023 Earnings Call Transcript – 2023-11-15 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 15-Nov-23 1:30pm GMT

PAVmed Inc Q2 2023 Earnings Call Transcript – 2023-08-16 – US$ 54.00 – Edited Transcript of PAVM.OQ earnings conference call or presentation 16-Aug-23 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "PAVmed Inc Q3 2024 Earnings Call Transcript" Nov 14, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2024-PAVmed-Inc-Earnings-Call-T16166970>
  
APA:
Thomson StreetEvents. (2024). PAVmed Inc Q3 2024 Earnings Call Transcript Nov 14, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2024-PAVmed-Inc-Earnings-Call-T16166970>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.